GlobeNewswire Inc.··NaTonix Pharma to Unveil Real-World Fibromyalgia Data as TONMYA Launch Gains Momentum
Tonix Pharmaceuticals will present real-world fibromyalgia analysis at ISPOR 2026, as its FDA-approved TONMYA drug shows strong early commercial uptake with 3,588 patients initiated in Q1 2026.
TNXPFDA approvalcommercial launch